Etrolizumab induction therapy improves patient-reported outcomes, endoscopic activity and histologic severity in patients with moderate-severe Ulcerative colitis after failure of anti-TNF therapy: results from the HICKORY open label induction trial
Zeitschrift für Gastroenterologie | September 22, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1055/s-0040-1716048